ENLV
Enlivex Therapeutics Ltd.
NASDAQHealthcareBiotechnologyIL
Rating:A+
Company Profile
CEO
Oren Hershkovitz
IPO Date
2014-07-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
IL
Enlivex Therapeutics Ltd.
CEO
Oren Hershkovitz
IPO Date
2014-07-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
IL
| 150,000 |
| $8.19 |
| 18 Mar 2026 | Hershkovitz Oren | Chief Executive Officer | Disposed | 60,000 | $5.34 |
| 18 Mar 2026 | Shlosberger Shachar | Chief Financial Officer | Disposed | 0 | $0.00 |
| 18 Mar 2026 | Shlosberger Shachar | Chief Financial Officer | Disposed | 1,452 | $2.69 |
| 18 Mar 2026 | Shlosberger Shachar | Chief Financial Officer | Disposed | 1,452 | $6.22 |
| 18 Mar 2026 | Shlosberger Shachar | Chief Financial Officer | Disposed | 5,000 | $4.68 |
| 18 Mar 2026 | Shlosberger Shachar | Chief Financial Officer | Disposed | 1,452 | $10.12 |
| 18 Mar 2026 | Shlosberger Shachar | Chief Financial Officer | Disposed | 10,000 | $3.21 |
| 18 Mar 2026 | Shlosberger Shachar | Chief Financial Officer | Disposed | 7,500 | $5.34 |